176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
34.15%
Revenue growth above 1.5x AMD's 16.86%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
41.62%
Gross profit growth above 1.5x AMD's 19.38%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
53.19%
EBIT growth below 50% of AMD's 134.57%. Michael Burry would suspect deeper competitive or cost structure issues.
53.19%
Operating income growth under 50% of AMD's 169.14%. Michael Burry would be concerned about deeper cost or sales issues.
49.37%
Net income growth under 50% of AMD's 190.94%. Michael Burry would suspect the firm is falling well behind a key competitor.
52.00%
EPS growth under 50% of AMD's 200.00%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
48.00%
Diluted EPS growth under 50% of AMD's 193.75%. Michael Burry would worry about an eroding competitive position or excessive dilution.
-0.20%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-0.20%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
-2.80%
Dividend reduction while AMD stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
15.50%
OCF growth above 1.5x AMD's 5.90%. David Dodd would confirm a clear edge in underlying cash generation.
16.42%
FCF growth 1.25-1.5x AMD's 12.98%. Bruce Berkowitz would see if capex decisions or cost controls create a cash flow advantage.
1518.55%
10Y revenue/share CAGR above 1.5x AMD's 150.38%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
462.25%
5Y revenue/share CAGR above 1.5x AMD's 156.39%. David Dodd would look for consistent product or market expansions fueling outperformance.
284.03%
3Y revenue/share CAGR above 1.5x AMD's 20.11%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
4152.63%
10Y OCF/share CAGR above 1.5x AMD's 1730.59%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
1386.02%
5Y OCF/share CAGR above 1.5x AMD's 81.73%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
474.19%
Positive 3Y OCF/share CAGR while AMD is negative. John Neff might see a big short-term edge in operational efficiency.
7228.78%
Net income/share CAGR above 1.5x AMD's 2279.63% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
641.72%
5Y net income/share CAGR above 1.5x AMD's 335.08%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
592.96%
Positive short-term CAGR while AMD is negative. John Neff would see a clear advantage in near-term profit trajectory.
624.82%
Below 50% of AMD's 5488.70%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
246.53%
Below 50% of AMD's 1673.35%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
117.29%
Below 50% of AMD's 506.64%. Michael Burry suspects a serious short-term disadvantage in building book value.
110.43%
Dividend/share CAGR of 110.43% while AMD is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
5.21%
Dividend/share CAGR of 5.21% while AMD is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
-1.86%
Negative near-term dividend growth while AMD invests at 0.00%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
17.59%
AR growth well above AMD's 25.93%. Michael Burry fears inflated revenue or higher default risk in the near future.
10.65%
Inventory growth well above AMD's 7.67%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
9.27%
Asset growth above 1.5x AMD's 2.58%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
21.20%
BV/share growth above 1.5x AMD's 3.05%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
0.67%
We have some new debt while AMD reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
12.45%
R&D growth drastically higher vs. AMD's 3.35%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
10.77%
SG&A growth well above AMD's 10.92%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.